Skip to main content
. 2022 Jul 5;25(3):286–292. doi: 10.4103/aca.aca_69_21

Table 2.

Outcomes measures

Variables Overall n=79 SAPB group n=43 ESPB group n=36 P
NRS 12 h 0.50 (0.00-3.00) 0.00 (0.00-3.50) 1.00 (0.00-2.00) 0.93
NRS 24 h 0.00 (0.00-2.00) 0.00 (0.00-3.50) 0.50 (0.00-2.00) 0.41
NRS 48 h 0.00 (0.00-2.00) 1.00 (0.00-3.00) 0.00 (0.00-2.00) 0.17
Morphine consumption 24 h (mg) 0.00 (0.00-2.00) 0.00 (0.00-0.00) 0.00 (0.00-0.75) 0.76
Morphine consumption 24-48 h (mg) 0.00 (0.00-0.00) 0.00 (0.00-0.00) 0.00 (0.00-0.00) 0.013*
Morphine total consumption (mg) 0.00 (0.00-3.00) 0.00 (0.00-4.00) 0.00 (0.00-3.00) 0.38

NRS: numeric rating scale; Morphine tot: total morphine consumption (continue infusion + rescue dose); Morphine consumption 24 h: total morphine doses in the first 24 postoperative hours; Morphine consumption 24-48: total morphine doses between 24 and 48 postoperative hours; SAPB, serratus anterior plane block; ESP, erector spinae plane block; *, significant result; Note: Results are presented as means with 95% confidence intervals